Detalhe da pesquisa
1.
CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor.
Immunity
; 56(1): 107-124.e5, 2023 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36580918
2.
An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma.
CA Cancer J Clin
; 72(5): 454-489, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35708940
3.
An intra-tumoral niche maintains and differentiates stem-like CD8 T cells.
Nature
; 576(7787): 465-470, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31827286
4.
Adrenocortical Carcinomas: Molecular Pathogenesis, Treatment Options, and Emerging Immunotherapy and Targeted Therapy Approaches.
Oncologist
; 2024 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38381694
5.
A plain language summary exploring a new treatment combination for untreated locally advanced or metastatic urothelial cancer: enfortumab vedotin plus pembrolizumab.
Future Oncol
; 20(7): 351-360, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37994649
6.
Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkers.
Cancer
; 129(24): 3884-3893, 2023 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37565840
7.
Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
Oncologist
; 28(3): 239-245, 2023 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36427017
8.
Immune Checkpoint Therapy Combinations in Adult Advanced MiT Family Translocation Renal Cell Carcinomas.
Oncologist
; 28(5): 433-439, 2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36640141
9.
Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors.
Oncologist
; 28(12): 1072-1078, 2023 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37285524
10.
Blood-Based Next-Generation Sequencing in Adrenocortical Carcinoma.
Oncologist
; 27(6): 462-468, 2022 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35462410
11.
Correlates of financial toxicity in adult cancer patients and their informal caregivers.
Support Care Cancer
; 30(1): 217-225, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34255179
12.
Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study.
Lancet Oncol
; 22(7): 946-958, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34143969
13.
Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinoma.
Cancer
; 127(12): 1974-1983, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33760232
14.
Clinical Outcomes and Racial Disparities in Metastatic Hormone-Sensitive Prostate Cancer in the Era of Novel Treatment Options.
Oncologist
; 26(11): 956-964, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34096667
15.
Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
Oncologist
; 26(10): e1742-e1750, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34156726
16.
Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors.
Oncologist
; 26(5): 397-405, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33634507
17.
Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors.
Oncologist
; 26(12): 1017-1025, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34342095
18.
Landscape of Immunotherapy in Genitourinary Malignancies.
Adv Exp Med Biol
; 1342: 143-192, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34972965
19.
Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trials.
Cancer
; 126(3): 575-582, 2020 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31648379
20.
Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
Oncologist
; 25(3): e484-e491, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32162798